- Work address
-
C. Heymanslaan 10
9000 Gent - Jan.DeWaele@UGent.be
- ORCID iD
-
https://orcid.org/0000-0003-1017-9748
- Bio (via ORCID)
- Jan De Waele is a surgery-trained intensivist with a specific interest in infections in critically ill patients and works at the surgical ICU of the Ghent University Hospital in Belgium. Clinical interests include infections and abdominal catastrophes such as the abdominal compartment syndrome. His research activities currently focus on optimizing antibiotic therapy in severely ill infected patients to improve outcome and combat resistance development. He is active in several societies: he is currently chairing the Infection Section of the ESICM and president of the Belgian Society of Intensive Care Medicine.
Show
Sort by
-
- journalArticle
- open access
Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients
-
- journalArticle
- open access
Persistence of piperacillin concentrations after treatment discontinuation: in cauda venenum?
-
Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial.
-
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units : protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project
-
Optimal duration of antibiotic treatment in Gram-negative infections.
-
Target attainment of empirically dosed continuous infusion of piperacillin/tazobactam and meropenem in critically ill patients
-
Continuous infusion piperacillin in critically ill patients: predicting concentrations using published population pharmacokinetic models
-
Impact of AST meetings on antimicrobial therapy decisions in the ICU
-
Emergence of antimicrobial resistance to piperacillin/tazobactam or meropenem in the ICU : intermittent versus continuous infusion : a retrospective cohort study
-
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models